Business - Briefly   

Astra to market Turbuhaler

By Our Staff Rerpoter

BANGALORE NOV. 17. Astra Zeneca PLC, Anglo-Swedish drug maker, will now sell its Symbicort Turbuhaler, a dry powder formulation inhaler for asthma, in India. A user will have to twist the Turbuhaler, not dissimilar to the way a lipstick is twisted, to get his dosage, which he must then inhale orally.

Lars Walan, Managing Director of Astra Zeneca Pharmaceuticals India Ltd. (AZPIL), the Indian marketing subsidiary of the MNC, told reporters on Monday, that Symbicort Turbuhaler, costing Rs. 1000 for a 60-dose unit would be available `on prescription only'.

An Astra Zeneca release said Symbicort delivered both the long lasting bronchodilator and the fast acting corticosteroid in the same dose.

Printer friendly page  
Send this article to Friends by E-Mail

Business

News: Front Page | National | Southern States | Other States | International | Opinion | Business | Sport | Miscellaneous |
Advts: Classifieds | Employment | Obituary |

Stories in this Section

• Banks asked to improve non-interest income
• Open access in power transmission allowed
• Indian Bank to raise Tier-II capital
• Rupee slumps against $
• IT exports on target
• Hudco cuts rates
• Kerala banks face takeover threat
• Sensex extends gains
• Stock Market Index
• Bullion rates
• Exchange rates
• Astra to market Turbuhaler
• Cranes to open subsidiary in Singapore
• ONGC eyes Russian co.
• Zee film division's new CEO

Copyright © 2003, The Hindu. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu